{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T20:41:26Z","timestamp":1782333686485,"version":"3.54.5"},"reference-count":90,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:00:00Z","timestamp":1758585600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Since the beginning of the COVID-19 pandemic, research has been ongoing to find the best diagnostic parameters to identify patients with a high risk of severe infection. Numerous studies have examined chemokine biomarkers in COVID-19 as a biomarker for high risk patients. The four main structural proteins of the SARS-CoV-2, spike protein, membrane protein, envelope protein and nucleocapsid protein enable the virus to penetrate host cells and stimulate the immune system. SARS-CoV-2 enters host cells via ACE2 in upper respiratory tract the virus entries by binding to the spike protein. Uncontrolled activation and enhancement of the immune response leads to massive release of cytokines and chemokines known as cytokine storm (CS). Chemokines are described as important cytokines in COVID-19 with a potential role as prognostic factor particularly for the severity of the infection and the risk of death from complications, to identify high-risk patients. Our review contains chemokines (CCL2, CCL3, CCL5, CXCL8, CXCL10), which level is significantly higher in patients with COVID-19 infection vs control individuals.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1662643","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T05:29:40Z","timestamp":1758605380000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Chemokines as potential biomarkers for predicting the course of COVID-19 \u2013 a review of the literature"],"prefix":"10.3389","volume":"16","author":[{"given":"Blanka","family":"Wolszczak-Biedrzycka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata","family":"Cie\u015blikiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip","family":"Studniarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0141ukasz","family":"D\u0105browski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateusz","family":"F\u0105s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystyna","family":"Matyszkiewicz\u2013Suchodolska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Harasimowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justyna","family":"Dorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,23]]},"reference":[{"key":"B1","unstructured":"COVID-19 Data Explorer - Our World in Data"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119201","article-title":"COVID-19, cytokines, inflammation, and spices: How are they related","volume":"284","author":"Kunnumakkara","year":"2021","journal-title":"Life Sci"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/biom11010091","article-title":"Cytokines and chemokines in SARS-CoV-2 infections\u2014 therapeutic strategies targeting cytokine storm","volume":"11","author":"Pum","year":"2021","journal-title":"Biomolecules"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.12669\/PJMS.37.7.4085","article-title":"Lymphopenia: A useful predictor of COVID-19 disease severity and mortality","volume":"37","author":"Toori","year":"2021","journal-title":"Pak J Med Sci"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1320362","article-title":"Changes in chemokine and growth factor levels may be useful biomarkers for monitoring disease severity in COVID-19 patients; a pilot study","volume":"14","author":"Wolszczak-Biedrzycka","year":"2024","journal-title":"Front Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S439217","article-title":"Unveiling COVID-19 secrets: harnessing cytokines as powerful biomarkers for diagnosis and predicting severity","volume":"16","author":"Wolszczak-Biedrzycka","year":"2023","journal-title":"J Inflammation Res"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.2147\/jir.s409871","article-title":"Neutrophil\/lymphocyte ratio (NLR) and lymphocyte\/monocyte ratio (LMR)\u2013 risk of death inflammatory biomarkers in patients with COVID-19","volume":"16","author":"Dymicka-Piekarska","year":"2023","journal-title":"J Inflammation Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.2147\/jir.s406658","article-title":"The diagnostic value of inflammatory markers (CRP, IL6, CRP\/IL6, CRP\/L, LCR) for assessing the severity of COVID-19 symptoms based on the MEWS and predicting the risk of mortality","volume":"16","author":"Wolszczak-Biedrzycka","year":"2023","journal-title":"J Inflammation Res"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S395331","article-title":"Clinical significance and diagnostic utility of NLR, LMR, PLR and SII in the course of COVID-19: A literature review","volume":"16","author":"Kosid\u0142o","year":"2023","journal-title":"J Inflammation Res"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S337488","article-title":"The role of different inflammatory indices in the diagnosis of COVID-19","volume":"14","author":"Eissa","year":"2021","journal-title":"Int J Gen Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1172\/JCI137647","article-title":"SARS-CoV-2: A storm is raging","volume":"130","author":"Pedersen","year":"2020","journal-title":"J Clin Invest"},{"key":"B12","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13073-022-01021-1","article-title":"Integrating single-cell sequencing data with GWAS summary statistics reveals CD16+monocytes and memory CD8+T cells involved in severe COVID-19","volume":"14","author":"Yunlong","year":"2022","journal-title":"Genome Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.xgen.2023.100383","article-title":"Polygenic regression uncovers trait-relevant cellular contexts through pathway activation transformation of single-cell RNA sequencing data","volume":"3","author":"Yunlong","year":"2023","journal-title":"Cell Genom"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01329-2","article-title":"Single-cell multi-omics analysis of the immune response in COVID-19","volume":"27","author":"Stephenson","year":"2021","journal-title":"Nat Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-020-0762-x","article-title":"Single-cell landscape of immunological responses in patients with COVID-19","volume":"21","author":"Ji-Yuan","year":"2020","journal-title":"Nat Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g7647","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"7647","author":"Shamseer","year":"2015","journal-title":"BMJ"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.09.018","article-title":"Molecular architecture of the SARS-coV-2 virus","volume":"183","author":"Yao","year":"2020","journal-title":"Cell"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-021-00573-0","article-title":"SARS-CoV-2 variants, spike mutations and immune escape","volume":"19","author":"Harvey","year":"2021","journal-title":"Nat Rev Microbiol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2021.104831","article-title":"Mutations in SARS-CoV-2; Consequences in structure, function, and pathogenicity of the virus","volume":"154","author":"Bakhshandeh","year":"2021","journal-title":"Microb Pathog"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and antigenicity of the SARS-coV-2 spike glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2020.10.004","article-title":"Mechanisms of SARS-coV-2 transmission and pathogenesis","volume":"41","author":"Harrison","year":"2020","journal-title":"Trends Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/nsr\/nwaa036","article-title":"On the Origin and continuing evolution of SARS-CoV-2","volume":"7","author":"Tang","year":"2020","journal-title":"Natl Sci Rev"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19619-7","article-title":"SARS-CoV-2 structure and replication characterized by in situ cryo-electron tomography","volume":"11","author":"Klein","year":"2020","journal-title":"Nat Commun"},{"key":"B24","doi-asserted-by":"publisher","first-page":"83","DOI":"10.18388\/PB.2020_321","article-title":"Charakterystyka wirusa SARS-CoV-2 i potencjalne farmakologiczne sposoby leczenia","volume":"66","author":"Pawlik","year":"2020","journal-title":"Postepy Biochem"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.23812\/CONTI-E","article-title":"Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies","volume":"34","author":"Conti","year":"2020","journal-title":"J Biol Regul Homeost Agents"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.14336\/AD.2021.0805","article-title":"ACE2 and COVID-19 susceptibility and severity","volume":"13","author":"Zheng","year":"2022","journal-title":"Aging Dis"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1136\/postgradmedj-2020-137935","article-title":"ACE2 and COVID-19 and the resulting ARDS","volume":"96","author":"Zhang","year":"2020","journal-title":"Postgrad Med J"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.868845","article-title":"Tryptophan metabolism and COVID-19-induced skeletal muscle damage: is ACE2 a key regulator","volume":"9","author":"Takeshita","year":"2022","journal-title":"Front Nutr"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-020-04089-y","article-title":"Expression and co-expression analyses of TMPRSS2, a key element in COVID-19","volume":"40","author":"Piva","year":"2021","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-022-00568-2","article-title":"The Golgi apparatus: Site for convergence of COVID-19 brain fog and Alzheimer\u2019s disease","volume":"17","author":"Wang","year":"2022","journal-title":"Mol Neurodegener"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abl4895","article-title":"SARS-CoV-2 nucleocapsid protein adheres to replication organelles before viral assembly at the Golgi\/ERGIC and lysosome-mediated egress","volume":"8","author":"Scherer","year":"2022","journal-title":"Sci Adv"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2022.110495","article-title":"COVID-19 signalome: Pathways for SARS-CoV-2 infection and impact on COVID-19 associated comorbidity","volume":"101","author":"Lundstrom","year":"2023","journal-title":"Cell Signal"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1186\/s41232-023-00259-5","article-title":"Innate immune recognition against SARS-CoV-2","volume":"43","author":"Yamada","year":"2023","journal-title":"Inflammation Regener"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1128\/msystems.00336-21","article-title":"Molecular mechanisms of the toll-like receptor, STING, MAVS, inflammasome, and interferon pathways","volume":"6","author":"Manes","year":"2021","journal-title":"MSystems"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.607221","article-title":"COVID-19 pathophysiology predicts that ischemic stroke occurrence is an expectation, not an exception\u2014A systematic review","volume":"11","author":"Wijeratne","year":"2021","journal-title":"Front Neurol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1440313","article-title":"The antioxidant barrier, oxidative\/nitrosative stress, and protein glycation in allergy: from basic research to clinical practice","author":"Biedrzycki","year":"2024","journal-title":"Front Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.71385","article-title":"Establishment and Validation of an Interferon-Stimulated Genes (ISGs) Prognostic Signature in Pan-cancer Patients: A Multicenter, Real-world Study","volume":"18","author":"Zheng","year":"2022","journal-title":"Int. J. Biol. Sci"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23084268","article-title":"Implications of SARS-coV-2 infection in systemic juvenile idiopathic arthritis","volume":"23","author":"Ailioaie","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-022-01085-6","article-title":"STAM and Hrs interact sequentially with IFN-\u03b1 Receptor to control spatiotemporal JAK\u2013STAT endosomal activation","volume":"25","author":"Zanin","year":"2023","journal-title":"Nat Cell Biol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00219-10","article-title":"Autocrine interferon priming in macrophages but not dendritic cells results in enhanced cytokine and chemokine production after coronavirus infection","volume":"1","author":"Zhou","year":"2010","journal-title":"MBio"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202201972RR","article-title":"Involvement of eNAMPT\/TLR4 inflammatory signaling in progression of non-alcoholic fatty liver disease, steatohepatitis, and fibrosis","volume":"37","author":"Sun","year":"2023","journal-title":"FASEB J"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-04444-9","article-title":"eNAMPT neutralization reduces preclinical ARDS severity via rectified NFkB and Akt\/mTORC2 signaling","volume":"12","author":"Bermudez","year":"2022","journal-title":"Sci Rep"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.20452\/PAMW.15658","article-title":"Management of SARS-CoV-2 infection: Recommendations of the polish association of epidemiologists and infectiologists. Annex no. 2 as of October 13, 2020","volume":"130","author":"Flisiak","year":"2020","journal-title":"Pol Arch Intern Med"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.120703","article-title":"SARS-CoV-2 infection- induced growth factors play differential roles in COVID-19 pathogenesis","volume":"304","author":"Gupta","year":"2022","journal-title":"Life Sci"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-022-00992-2","article-title":"COVID-19 and the role of cytokines in this disease","volume":"30","author":"Hasanvand","year":"2022","journal-title":"Inflammopharmacology"},{"key":"B46","author":"Alturaiki","year":""},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2020.1799669","article-title":"Cytokines and COVID-19: friends or foes","volume":"16","author":"Rokni","year":"2020","journal-title":"Hum Vaccin Immunother"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.15789\/2220-7619-PVO-2043","article-title":"PREDICTIVE VALUE OF SPECIFIC CYTOKINES FOR LETHAL COVID-19 OUTCOME","volume":"12","author":"Arsentieva","year":"2022","journal-title":"Russian J Infect Immun"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2020.108615","article-title":"An enlightening role for cytokine storm in coronavirus infection","volume":"222","author":"Zhao","year":"2021","journal-title":"Clin Immunol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.833967","article-title":"Targeting TNF-\u03b1 for COVID-19: recent advanced and controversies","volume":"10","author":"Guo","year":"2022","journal-title":"Front Public Health"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2023.1145840\/BIBTEX","article-title":"Serum IL-23, IL-10, and TNF-\u03b1 predict in-hospital mortality in COVID-19 patients","volume":"14","author":"Smail","year":"2023","journal-title":"Front Immunol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1515\/dmpt-2021-0127","article-title":"Modifying effects of TNF-\u03b1, IL-6 and VDR genes on the development risk and the course of COVID-19. Pilot study","volume":"37","author":"Fishchuk","year":"2022","journal-title":"Drug Metab Pers Ther"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2009.00367.x","article-title":"A crucial role for TNF-\u03b1 in mediating neutrophil influx induced by endogenously generated or exogenous chemokines, KC\/CXCL1 and LIX\/CXCL5: RESEARCH PAPER","volume":"158","author":"Vieira","year":"2009","journal-title":"Br J Pharmacol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.2144\/FSOA-2022-0082\/ASSET\/IMAGES\/LARGE\/FIGURE4.JPEG","article-title":"Ct, IL-18 polymorphism, and laboratory biomarkers for predicting Chemosensory dysfunctions and mortality in COVID-19","volume":"9","author":"Smail","year":"2023","journal-title":"Future Sci OA"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2020.05.003","article-title":"The cytokine storm in COVID-19: An overview of the involvement of the chemokine\/chemokine-receptor system","volume":"53","author":"Coperchini","year":"2020","journal-title":"Cytokine Growth Factor Rev"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.csbj.2021.01.034","article-title":"Chemokines and chemokine receptors during COVID-19 infection","volume":"19","author":"Khalil","year":"2021","journal-title":"Comput Struct Biotechnol J"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2022.2017282","article-title":"Evaluating the role of chemokines and chemokine receptors involved in Coronavirus infection","volume":"18","author":"Olivarria","year":"2022","journal-title":"Expert Rev Clin Immunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1111\/sji.12492","article-title":"Chemokine patterns in children with acute bacterial infections","volume":"84","author":"Cavalcanti","year":"2016","journal-title":"Scand J Immunol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002497","article-title":"Enhancement of chemokine function as an immunomodulatory strategy employed by human herpesviruses","volume":"8","author":"Viejo-Borbolla","year":"2012","journal-title":"PloS Pathog"},{"key":"B60","unstructured":"NCT04569877, GM-CSF inhalation to prevent ARDS in COVID-19Pneumonia\n          \n          \n          2020"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-020-03427-y","article-title":"Alveolar compartmentalization of inflammatory and immune cell biomarkers in pneumonia-related ARDS","volume":"25","author":"Bendib","year":"2021","journal-title":"Crit Care"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.573421","article-title":"Complications and pathophysiology of COVID-19 in the nervous system","volume":"11","author":"Yu","year":"2020","journal-title":"Front Neurol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-13-198","article-title":"Interceptors:\u2013\u201dsilent\u201d chemokine receptors","volume":"61","author":"Grodecka","year":"2007","journal-title":"Postepy Hig Med Dosw"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v95.10.3032.010k17_3032_3043","article-title":"Chemokine receptors and their role in inflammation and infectious diseases","volume":"95","author":"Murdoch","year":"2000","journal-title":"Blood"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1038\/ni.f.214","article-title":"Chemokines and leukocyte traffic","volume":"9","author":"Sallusto","year":"2008","journal-title":"Nat Immunol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/4558159","article-title":"CXC chemokines in the pathogenesis of pulmonary disease and pharmacological relevance","author":"Komolafe","year":"2022","journal-title":"Int J Inflam"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/0888-7543(91)90239-B","article-title":"Localization of monocyte chemotactic protein-1 gene (SCYA2) to human chromosome 17q11.2-q21.1","volume":"9","author":"Mehrabian","year":"1991","journal-title":"Genomics"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1084\/jem.175.5.1271","article-title":"Monocyte chemotactic protein 1 is a potent activator of human basophils","volume":"175","author":"Bischoff","year":"1992","journal-title":"J Exp Med"},{"key":"B69","article-title":"Monocyte chemotactic protein-1 provokes mast cell aggregation and [3H]5HT release","volume":"86","author":"Conti","year":"1995","journal-title":"Immunology"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/18.11.3261","article-title":"Two inflammatory mediator cytokine genes are closely linked and variably amplified on chromosome 17q","volume":"18","author":"Irving","year":"1990","journal-title":"Nucleic Acids Res"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2019.4135","article-title":"4\u2019-O-Methylalpinumisoflavone inhibits the activation of monocytes\/macrophages to an immunostimulatory phenotype induced by 27-hydroxycholesterol","volume":"43","author":"Lee","year":"2019","journal-title":"Int J Mol Med"},{"key":"B72","doi-asserted-by":"crossref","DOI":"10.1007\/978-94-007-7696-8_27","article-title":"Macrophage Inflammatory Protein-1 Alpha (MIP-1 alpha)\/CCL3: As a biomarker","volume-title":"General methods in Biomarker Research and Their Applications","author":"Bhavsar","year":"2015"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2017.1384313","article-title":"Chemokines as adjuvants for immunotherapy: implications for immune activation with CCL3","volume":"13","author":"Schaller","year":"2017","journal-title":"Expert Rev Clin Immunol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/0888-7543(90)90485-D","article-title":"Localization of a human T-cell-specific gene, RANTES (D17S136E), to chromosome 17q11.2-q12","volume":"6","author":"Donlon","year":"1990","journal-title":"Genomics"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2021.08.004","article-title":"CCL5\/CCR5 axis in human diseases and related treatments","volume":"9","author":"Zeng","year":"2022","journal-title":"Genes Dis"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/S1471-4906(00)01812-3","article-title":"RANTES: A versatile and controversial chemokine","volume":"22","author":"Appay","year":"2001","journal-title":"Trends Immunol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830260207","article-title":"CC chemokines induce the generation of killer cells from CD56+ cells","volume":"26","author":"Maghazachi","year":"1996","journal-title":"Eur J Immunol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1038\/ncpneph0418","article-title":"Mechanisms of disease: Regulation of RANTES (CCL5) in renal disease","volume":"3","author":"Krensky","year":"2007","journal-title":"Nat Clin Pract Nephrol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.582935","article-title":"Cytokines and soluble HLA-G levels in the acute and recovery phases of arbovirus-infected Brazilian patients exhibiting neurological complications","volume":"12","author":"Almeida","year":"2021","journal-title":"Front Immunol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1007\/BF00208938","article-title":"Monocyte-derived neutrophil chemotactic factor (MDNCF\/IL-8) resides in a gene cluster along with several other members of the platelet factor 4 gene superfamily","volume":"84","author":"Modi","year":"1990","journal-title":"Hum Genet"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2012.00188","article-title":"Chemokines, selectins and intracellular calcium flux: Temporal and spatial cues for leukocyte arrest","volume":"3","author":"Dixit","year":"2012","journal-title":"Front Immunol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232314574","article-title":"IL-6 and IL-8: an overview of their roles in healthy and pathological pregnancies","volume":"23","author":"Viloti\u0107","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2019.1696075","article-title":"Significance of the IL-8 pathway for immunotherapy","volume":"16","author":"Gonzalez-Aparicio","year":"2020","journal-title":"Hum Vaccin Immunother"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/2755246","article-title":"Associations between serum interleukins (IL-1 \u03b2, IL-2, IL-4, IL-6, IL-8, and IL-10) and disease severity of COVID-19: A systematic review and meta-analysis","volume":"2022","author":"Chang","year":"2022","journal-title":"BioMed Res Int"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2022.155804","article-title":"Cytokine profiles in the detection of severe lung involvement in hospitalized patients with COVID-19: The IL-8\/IL-32 axis","volume":"151","author":"Bergantini","year":"2022","journal-title":"Cytokine"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1038\/315672a0","article-title":"\u03b3-Interferon transcriptionally regulates an early-response gene containing homology to platelet proteins","volume":"315","author":"Luster","year":"1985","journal-title":"Nature"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1021\/bi026020q","article-title":"The CXCR3 binding chemokine IP-10\/CXCL10: Structure and receptor interactions","volume":"41","author":"Booth","year":"2002","journal-title":"Biochemistry"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M212077200","article-title":"CXCR3 and heparin binding sites of the chemokine IP-10 (CXCL10)","volume":"278","author":"Campanella","year":"2003","journal-title":"J Biol Chem"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23073673","article-title":"What is currently known about the role of\u00a0CXCL10 in SARS-coV-2 infection","volume":"23","author":"Gudowska-Sawczuk","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1177\/1073858420939033","article-title":"COVID-19 pulmonary and olfactory dysfunctions: is the chemokine CXCL10 the common denominator","volume":"27","author":"Oliviero","year":"2021","journal-title":"Neuroscientist"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1662643\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T05:29:42Z","timestamp":1758605382000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1662643\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,23]]},"references-count":90,"alternative-id":["10.3389\/fimmu.2025.1662643"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1662643","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,23]]},"article-number":"1662643"}}